TY - JOUR
T1 - One-food versus 4-food elimination diet for pediatric eosinophilic esophagitis
T2 - A multisite randomized trial
AU - Kliewer, Kara L.
AU - Abonia, J. Pablo
AU - Aceves, Seema S.
AU - Atkins, Dan
AU - Bonis, Peter A.
AU - Capocelli, Kelley E.
AU - Chehade, Mirna
AU - Collins, Margaret H.
AU - Dellon, Evan S.
AU - Fei, Lin
AU - Furuta, Glenn T.
AU - Gupta, Sandeep K.
AU - Kagalwalla, Amir
AU - Leung, John
AU - Mir, Sabina
AU - Mukkada, Vincent A.
AU - Pesek, Robbie
AU - Rosenberg, Chen
AU - Shoda, Tetsuo
AU - Spergel, Jonathan M.
AU - Sun, Qin
AU - Wechsler, Joshua B.
AU - Yang, Guang Yu
AU - Rothenberg, Marc E.
N1 - Publisher Copyright:
© 2024 American Academy of Allergy, Asthma & Immunology
PY - 2025/2
Y1 - 2025/2
N2 - Background: A 6-food elimination diet in pediatric eosinophilic esophagitis (EoE) is difficult to implement and may negatively affect quality of life (QoL). Less restrictive elimination diets may balance QoL and efficacy. Objective: We performed a multisite, randomized comparative efficacy trial of a 1-food (milk) elimination diet (1FED) versus 4-food (milk, egg, wheat, soy) elimination diet (4FED) in pediatric EoE. Methods: Patients aged 6 to 17 years with histologically active and symptomatic EoE were randomized 1:1 to 1FED or 4FED for 12 weeks. Primary end point was symptom improvement by Pediatric Eosinophilic Esophagitis Symptom Score (PEESS). Secondary end points were proportion experiencing histologic remission (<15 eosinophils per high-power field); change in histologic features (histology scoring system), endoscopic severity (endoscopic reference score), transcriptome (EoE diagnostic panel), and QoL scores; and predictors of remission. Results: Sixty-three patients were randomly assigned to 1FED (n = 38) and 4FED (n = 25). In 4FED versus 1FED, mean PEESS improved −25.0 versus −14.5 (P =.04), but remission rates (41% vs 44%; P = 1.00), histology scoring system (−0.25 vs −0.29; P =.77), endoscopic reference score (−1.10 vs −0.58; P =.47), and QoL scores were similar between groups. The EoE transcriptome normalized in those with histologic response to both diets. Baseline peak eosinophil count predicted remission (odds ratio, 0.975 [95% confidence interval, 0.953-0.999], P =.04; cutoff ≤42 eosinophils per high-power field). The 4FED withdrawal rate (32%) exceeded that of 1FED (11%) (P =.0496). Conclusions: Although 4FED moderately improved symptoms compared with 1FED, the histologic, endoscopic, QoL, and transcriptomic outcomes were similar in both groups. 1FED is a reasonable first-choice therapy for pediatric EoE, given its effects, tolerability, and relative simplicity.
AB - Background: A 6-food elimination diet in pediatric eosinophilic esophagitis (EoE) is difficult to implement and may negatively affect quality of life (QoL). Less restrictive elimination diets may balance QoL and efficacy. Objective: We performed a multisite, randomized comparative efficacy trial of a 1-food (milk) elimination diet (1FED) versus 4-food (milk, egg, wheat, soy) elimination diet (4FED) in pediatric EoE. Methods: Patients aged 6 to 17 years with histologically active and symptomatic EoE were randomized 1:1 to 1FED or 4FED for 12 weeks. Primary end point was symptom improvement by Pediatric Eosinophilic Esophagitis Symptom Score (PEESS). Secondary end points were proportion experiencing histologic remission (<15 eosinophils per high-power field); change in histologic features (histology scoring system), endoscopic severity (endoscopic reference score), transcriptome (EoE diagnostic panel), and QoL scores; and predictors of remission. Results: Sixty-three patients were randomly assigned to 1FED (n = 38) and 4FED (n = 25). In 4FED versus 1FED, mean PEESS improved −25.0 versus −14.5 (P =.04), but remission rates (41% vs 44%; P = 1.00), histology scoring system (−0.25 vs −0.29; P =.77), endoscopic reference score (−1.10 vs −0.58; P =.47), and QoL scores were similar between groups. The EoE transcriptome normalized in those with histologic response to both diets. Baseline peak eosinophil count predicted remission (odds ratio, 0.975 [95% confidence interval, 0.953-0.999], P =.04; cutoff ≤42 eosinophils per high-power field). The 4FED withdrawal rate (32%) exceeded that of 1FED (11%) (P =.0496). Conclusions: Although 4FED moderately improved symptoms compared with 1FED, the histologic, endoscopic, QoL, and transcriptomic outcomes were similar in both groups. 1FED is a reasonable first-choice therapy for pediatric EoE, given its effects, tolerability, and relative simplicity.
KW - Eosinophilic esophagitis
KW - comparative effectiveness
KW - elimination diet
KW - milk
KW - quality of life
UR - https://www.scopus.com/pages/publications/85204788274
U2 - 10.1016/j.jaci.2024.08.023
DO - 10.1016/j.jaci.2024.08.023
M3 - Article
C2 - 39233016
AN - SCOPUS:85204788274
SN - 0091-6749
VL - 155
SP - 520
EP - 532
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 2
ER -